ILMN
Illumina Inc.
$219.40
+2.89%
2026-08-21
About Illumina Inc.
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. The company has a collaboration with Labcorp Holdings Inc. for the development of oncology treatments through applications of sequencing solutions across the healthcare ecosystem; and strategic collaboration with Integrated DNA Technologies to enable a DRAGEN, secondary analysis pipeline for IDT xGena, FFPE and cfDNA next generation sequencing (NGS) library preparation with custom panels, delivering an integrated, end-to-end solution for somatic oncology research. It also has a data partnership with Center for Data-Driven Discovery in Biomedicine to advance research in pediatric cancer and rare disease. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
Key Fundamentals
P/E Ratio
35.61
Forward P/E
31.31
EPS (TTM)
$5.36
ROE
32.3%
Revenue Growth (YoY)
9.4%
Profit Margin
18.3%
Debt/Equity
89.04
Price/Book
10.16
Beta
1.46
Market Cap
$28.82B
Avg Volume (10D)
2.0M
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$220.43
60D Low
$150.10
Avg Volume
2.0M
Latest Close
$219.40
Get breakout alerts for ILMN
Sign up for Breakout Scanner to receive daily notifications when ILMN triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
Illumina Inc. (ILMN) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors ILMN daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. ILMN operates in the Healthcare sector within the Diagnostics & Research industry. Data is provided for informational purposes only and does not constitute financial advice.